“I hope the same does not occur for leronlimab.
Post# of 148190
The vaccine became a political subject/tool, leronlimab will not, especially given the S/C trial has completed.
“It is eminently unsettling when patients start doubting their physicians.”
I’ve spent extensive time explaining the vaccines to patients, including the trial design, sample size, and safety data. Regardless, some still do not trust the vaccine even though SAEs have been minimal (the news reports of a few allergic/anaphylactic reactions has scared many). I’m approaching the 21 day mark for my second Pfizer shot and I only had soreness at the injection site and I don’t personally know any healthcare worker who’s had anything beyond pain at the injection site and/or a headache the next day.
Read More: https://investorshangout.com/post/newpost/605...z6jC6qt5M5